We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
576
Honeywell
HON
$76.4B
$1M 0.01%
5,182
+257
+5% +$48.4K
ESS icon
577
Essex Property Trust
ESS
$19.1B
$999K 0.01%
4,082
+341
+9% +$81.2K
HRL icon
578
Hormel Foods
HRL
$14.2B
$974K 0.01%
27,924
-2,856
-9% -$91.1K
EQT icon
579
EQT Corp
EQT
$32.9B
$942K 0.01%
25,410
-69
-0.3% -$2.47K
MCHP icon
580
Microchip Technology
MCHP
$38.8B
$908K 0.01%
10,118
+1,001
+11% +$86.3K
CF icon
581
CF Industries
CF
$19.6B
$906K 0.01%
10,886
+1,274
+13% +$102K
BURL icon
582
Burlington
BURL
$23.4B
$904K 0.01%
3,892
+482
+14% +$98.3K
KEY icon
583
KeyCorp
KEY
$23.8B
$900K 0.01%
56,910
+4,612
+9% +$66.6K
TYL icon
584
Tyler Technologies
TYL
$13.7B
$898K 0.01%
2,113
+27
+1% +$11.5K
CVSA
585
Covista Inc
CVSA
$4.55B
$874K 0.01%
+17,000
New +$888K
TAP icon
586
Molson Coors Class B
TAP
$8.02B
$872K 0.01%
12,966
+1,692
+15% +$107K
RVTY icon
587
Revvity
RVTY
$12.6B
$853K 0.01%
8,122
+842
+12% +$89.6K
CTRA
588
DELISTED
Coterra Energy
CTRA
$851K 0.01%
30,517
-6,786
-18% -$174K
CINF icon
589
Cincinnati Financial
CINF
$27.8B
$848K 0.01%
6,830
-560
-8% -$63.2K
KB icon
590
KB Financial Group
KB
$39.5B
$833K 0.01%
+16,000
New +$755K
GATX icon
591
GATX Corp
GATX
$6.45B
$809K 0.01%
6,033
-19,161
-76% -$2.41M
PAYC icon
592
Paycom
PAYC
$7.88B
$785K 0.01%
3,944
-35,519
-90% -$6.79M
CTLT
593
DELISTED
CATALENT, INC.
CTLT
$780K 0.01%
13,826
+1,048
+8% +$56.8K
GS icon
594
Goldman Sachs
GS
$289B
$762K ﹤0.01%
1,825
+55
+3% +$21.3K
FCNCA icon
595
First Citizens BancShares
FCNCA
$24.7B
$749K ﹤0.01%
458
+73
+19% +$110K
EPAM icon
596
EPAM Systems
EPAM
$5.58B
$748K ﹤0.01%
2,707
HURN icon
597
Huron Consulting
HURN
$2.76B
$722K ﹤0.01%
7,470
LBTYK icon
598
Liberty Global Class C
LBTYK
$3.5B
$720K ﹤0.01%
40,800
+12,671
+45% +$244K
EQH icon
599
Equitable Holdings
EQH
$13.2B
$712K ﹤0.01%
18,743
-3,082
-14% -$105K
TFX icon
600
Teleflex
TFX
$5.96B
$699K ﹤0.01%
3,090
+408
+15% +$96.9K

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.